Accessible Search Form           Advanced Search

HHS logo

Embargoed for Release: November 4, 2012, 7:36 PM EST

NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
Ask for press officer on duty

Embargoed for Release: November 4, 2012, 7:36 PM EST

  • PRINT  |  SHARE

Statement from NHLBI Director Gary H. Gibbons, M.D.

The National Heart, Lung, and Blood Institute (NHLBI) congratulates the principal investigators and scientific team carrying out the Trial to Assess Chelation Therapy (TACT).

Between 2002 and 2007, use of chelation therapy grew by nearly 68 percent to 111,000 people -- despite there being no evidence as to its safety or efficacy. Given that so many people are trying chelation therapy, it was imperative that a large-scale and very rigorous study be undertaken. The NHLBI is proud to have helped fund such a project.

Preliminary results, which will be released during the American Heart Association’s 2012 Scientific Sessions, found that a chelation regimen is safe in the context of a clinical trial and suggest that there may be benefits in some patients with coronary heart disease. However, further research is needed, including replication of the results and research to determine whether the intervention can be safely and reliably delivered in a general practice setting, before chelation can be considered as a potential mainstream treatment option.

Because the study manuscript is currently under peer review, the NHLBI will refrain from further comment on the results until publication.


Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute (NHLBI) plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at http://www.nhlbi.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH...Turning Discovery Into Health

For the Media

NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
Ask for press officer on duty

Related Health Topics

Coronary Heart Disease